We are a global end-to-end biologics and small molecule Contract Development and Manufacturing Organization (CDMO), offering the highest-quality, cost-effective clinical and commercial Drug Substance and sterile Drug Product manufacture.
Our services span development and clinical and commercial manufacturing for microbial, pDNA, mRNA and LNP-based products, and sterile filling of small and large molecule products in multiple formats.
Trust our US FDA, EMA, and TGA-approved facilities in South and Western Australia, with our highly client-centric approach and industry leading reliability.
BioCina’s strategic location in Australia affords clients accelerated timelines to clinical trials & preeminent tax incentives, ensuring faster payback on investment. Combined with our performance across quality, timeline, capacity, & capability, we provide everything clients care about the most.